Literature DB >> 27123741

Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation.

C E Kiserud1, U-M Fagerli2,3, K B Smeland1,4, Ø Fluge5, H Bersvendsen6, S Kvaløy1,4, H Holte1, A A Dahl1,4.   

Abstract

Background This study examined employment patterns and associated factors in lymphoma survivors treated with high-dose chemotherapy with autologous stem cell transplantation (HDT-ASCT) from diagnosis to a follow-up survey at a mean of 10 years after HDT-ASCT. Patients and methods All lymphoma survivors aged ≥18 years at HDT-ASCT in Norway from 1987 to 2008, and alive at the end of 2011 were eligible for this cross-sectional study performed in 2012/2013. Participants completed a mailed questionnaire. Job status was dichotomized as either employed (paid work) or not-employed (disability and retirement pension, on economic support, home-makers, or students). Results The response rate was 78%, and the sample (N = 312) contained 60% men. Mean age at HDT-ASCT was 44.3 and at survey 54.0 years. At diagnosis 85% of survivors were employed, 77% before and 77% after HDT-ASCT, and 58% at follow-up. Forty seven percent of the survivors were employed at all time points. The not-employed group at survey was significantly older and included significantly more females than the employed group. No significant between-group differences were observed for lymphoma-related variables. Fatigue, mental distress and type D personality were significantly higher among those not-employed, while quality of life was significantly lower compared to the employed group. Older age at survey, being female, work ability and presence of type D personality remained significantly related to being not-employed at survey in the multivariable analysis. Conclusions Our findings show that not-employed long-term survivors after HDT-ASCT for lymphoma have more comorbidity, cognitive problems and higher levels of anxiety/depression than employed survivors. These factors should be checked and eventually treated in order to improve work ability.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27123741     DOI: 10.3109/0284186X.2015.1125015

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  8 in total

1.  Inability to work and need for disability pension among long-term survivors of hematopoietic stem cell transplantation.

Authors:  A Tichelli; S Gerull; A Holbro; A Buser; G Nair; M Medinger; D Heim; J P Halter; J R Passweg
Journal:  Bone Marrow Transplant       Date:  2017-06-26       Impact factor: 5.483

Review 2.  Prevalence and Determinants of Return to Work as a Patient-Centered Outcome in Survivors of Hematopoietic Cell Transplantation.

Authors:  Neel S Bhatt
Journal:  Curr Hematol Malig Rep       Date:  2022-10-04       Impact factor: 4.213

3.  Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation.

Authors:  Hanne Skjerven Bersvendsen; Hege Sagstuen Haugnes; Alv A Dahl; Unn-Merete Fagerli; Øystein Fluge; Harald Holte; Mette Seland; Tom Wilsgaard; Knut Bjøro Smeland; Cecilie Essholt Kiserud
Journal:  Bone Marrow Transplant       Date:  2019-11-19       Impact factor: 5.483

4.  Return to work for patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation.

Authors:  Bente Arboe; Maja Halgren Olsen; Jette Soenderskov Goerloev; Anne Katrine Duun-Henriksen; Christoffer Johansen; Susanne Oksbjerg Dalton; Peter de Nully Brown
Journal:  Clin Epidemiol       Date:  2017-06-06       Impact factor: 4.790

5.  Long-term work retention after treatment for cancer: a systematic review and meta-analysis.

Authors:  Angela Gem de Boer; Steffen Torp; Adela Popa; Trine Horsboel; Vesna Zadnik; Yakir Rottenberg; Edit Bardi; Ute Bultmann; Linda Sharp
Journal:  J Cancer Surviv       Date:  2020-03-11       Impact factor: 4.442

6.  Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation.

Authors:  Kjersti Helene Hernæs; Knut B Smeland; Unn-Merete Fagerli; Cecilie E Kiserud
Journal:  BMC Cancer       Date:  2021-02-08       Impact factor: 4.430

Review 7.  Investigating how cancer-related symptoms influence work outcomes among cancer survivors: a systematic review.

Authors:  Chia Jie Tan; Samantha Yin Ching Yip; Raymond Javan Chan; Lita Chew; Alexandre Chan
Journal:  J Cancer Surviv       Date:  2021-08-23       Impact factor: 4.062

8.  Assessment of cognitive function in long-term Hodgkin lymphoma survivors, results based on data from a major treatment center in Hungary.

Authors:  Ferenc Magyari; István Virga; Zsófia Simon; Zsófia Miltényi; Anna Illés; Karolina Kósa; Tibor Ivánka; Roland Berecz; Anikó Égerházi; Árpád Illés
Journal:  Support Care Cancer       Date:  2022-03-11       Impact factor: 3.359

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.